New to Medicare: Some DNA Tests

Share this story on:

Share on facebook
Share on twitter
Share on linkedin

“The CMS announced Friday that it will cover diagnostic laboratory tests using gene sequencing technology for Medicare cancer patients.

“The CMS said the tests — called next generation sequencing — can help patients and their oncologists make better treatment decisions as well as help more patients enroll in clinical trials. Patients with recurrent, metastatic, relapsed, refractory or stages III or IV cancers will be eligible to get the tests covered under Medicare, according to the agency.

“‘We want cancer patients to have enhanced access and expanded coverage when it comes to innovative diagnostics that can help them in new and better ways,’ said CMS Administrator Seema Verma in a statement. ‘That is why we are establishing clear pathways to coverage, while at the same time supporting laboratories that currently furnish tests to the people we serve.’

“The CMS’ decision to cover such tests comes shortly after the FDA’s recent approval of Foundation Medicine’s genomic profiling test called FoundationOne CDx. The CMS worked with the FDA to review the effectiveness of the test.” Source: Maria Castellucci, Modern Healthcare.

Teresa
Teresa

Recent Posts

Teresa

Indiana Update

Over 954,000 people in the state of Indiana have been fully vaccinated against COVID-19. There are 548 people in Indiana hospitals because of COVID-19; and

Read More »
Teresa

Unprecedented Collaboration

“… COVID 19 has led to unprecedented worldwide collaboration among scientists, medical doctors, health and government officials, and manufacturers…The arrival of this vaccine in Michigan

Read More »
Teresa

Questions about Vaccines?

“People with questions about vaccines – including the COVID 19 vaccination should consult a creditable source with answers based on medical science.  Sources for vaccination

Read More »

copyright 2020 Evansville Insurance Center